Cargando…

Diagnostic Accuracy of Imaging Modalities in the Evaluation of Vascular Invasion in Pancreatic Adenocarcinoma: A Meta-Analysis

BACKGROUND: The extent of vascular invasion is a key factor determining the resectability of non-metastatic pancreatic adenocarcinoma. The purpose of this study is to determine the diagnostic accuracy of computed tomography (CT), endoscopic ultrasound (EUS), and magnetic resonance imaging (MRI) in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Angela E., Li, Bob T., Ng, Bernard H.K., McCormack, Sam, Vedelago, John, Clarke, Stephen, Pavlakis, Nick, Samra, Jaswinder
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649672/ https://www.ncbi.nlm.nih.gov/pubmed/29147335 http://dx.doi.org/10.4021/wjon657w

Ejemplares similares

The role of staging laparoscopy in pancreatic adenocarcinoma and its effect on patients’ survival
por: Jambor, Maxwell A., et al.
Publicado: (2022)

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy
por: Sahni, Sumit, et al.
Publicado: (2023)

Dramatic response to selective internal radiation therapy for unresectable hepatocellular carcinoma
por: Park, Woo Daniel, et al.
Publicado: (2015)

The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer
por: Maloney, Sarah, et al.
Publicado: (2023)

Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET)
por: Wong, Matthew H., et al.
Publicado: (2016)

Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?
por: Gillson, Josef, et al.
Publicado: (2020)

The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma
por: Parkin, Ashleigh, et al.
Publicado: (2018)

Enduring complete metabolic response in metastatic adenocarcinoma of the gastro-oesophageal junction
por: Li, Minmin, et al.
Publicado: (2014)

Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors
por: Mehta, Shreya, et al.
Publicado: (2015)

Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target
por: Gillson, Josef, et al.
Publicado: (2022)

Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis
por: Maloney, Sarah, et al.
Publicado: (2021)

Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy
por: Sahni, Sumit, et al.
Publicado: (2020)

The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resectable Pancreatic Cancer
por: Nahm, Christopher B., et al.
Publicado: (2022)

The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer
por: Maloney, Sarah, et al.
Publicado: (2023)

Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis
por: Byeon, Sooin, et al.
Publicado: (2023)

Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma
por: Tayao, Michael, et al.
Publicado: (2016)

Drain fluid biomarkers for the diagnosis of clinically relevant postoperative pancreatic fistula: a diagnostic accuracy systematic review and meta-analysis
por: Rykina-Tameeva, Nadya, et al.
Publicado: (2023)

Postoperative pancreatic fistula: a review of traditional and emerging concepts
por: Nahm, Christopher B, et al.
Publicado: (2018)

Drain fluid biomarkers for prediction and diagnosis of clinically relevant postoperative pancreatic fistula: A narrative review
por: Rykina-Tameeva, Nadya, et al.
Publicado: (2022)

Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice
por: Li, Bob T., et al.
Publicado: (2014)

Educational Case: Pancreatic Adenocarcinoma: Clinical Presentation, Pathogenesis, Diagnostic, and Therapeutic Modalities
por: Dombrowski, Katya, et al.
Publicado: (2020)

Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Ductal Adenocarcinoma()
por: Wong, Matthew H., et al.
Publicado: (2016)

Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance
por: Chan, David LH, et al.
Publicado: (2017)

Surgical management of high-grade pancreatic injuries: Insights from a high-volume pancreaticobiliary specialty unit
por: Chui, Juanita Noeline, et al.
Publicado: (2023)

High accuracy differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma by immunoglobulin G glycosylation
por: Shih, Hsi-Chang, et al.
Publicado: (2019)

Multivisceral resection of pancreatic neuroendocrine tumours: a report of two cases
por: Gundara, Justin S, et al.
Publicado: (2011)

ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma
por: Oria, Victor O., et al.
Publicado: (2019)

Accuracy of registration techniques and vascular imaging modalities in fusion imaging for aortic endovascular interventions: a phantom study
por: Sieren, M. M., et al.
Publicado: (2021)

Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis
por: Stephenson, David, et al.
Publicado: (2017)

Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches
por: Orth, Michael, et al.
Publicado: (2019)

Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities
por: Gkika, E., et al.
Publicado: (2023)

Novel investigative modalities for evaluation of pancreatic cystic lesions: Does increased diagnostic accuracy justify the high costs?
por: Krishna, Somashekar G.
Publicado: (2017)

Controversies in the Management of Borderline Resectable Proximal Pancreatic Adenocarcinoma with Vascular Involvement
por: Tucker, Olga N., et al.
Publicado: (2008)

Vascularization, Oxygenation, and the Effect of Sunitinib Treatment in Pancreatic Ductal Adenocarcinoma Xenografts
por: Gaustad, Jon-Vidar, et al.
Publicado: (2019)

Inflammatory cytokines and combined biomarker panels in pancreatic ductal adenocarcinoma: Enhancing diagnostic accuracy
por: Kruger, Deirdré, et al.
Publicado: (2019)

Overall survival and treatment modalities in pancreatic adenocarcinoma: a retrospective analysis of a single centre in Western Australia
por: Talbot, Alice, et al.
Publicado: (2023)

Ultrahigh accuracy imaging modality for super-localization microscopy
por: Chao, Jerry, et al.
Publicado: (2013)

Anti-PD-1 Monoclonal Antibodies (mAbs) Are Superior to Anti-PD-L1 mAbs When Combined with Chemotherapy in First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Network Meta-Analysis
por: Wei, Joe Q., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ndvmqpteg8425nhb58gkgsnkc5